Presentation is loading. Please wait.

Presentation is loading. Please wait.

Transapical aortic valve implantation in patients with severely depressed left ventricular function  Axel Unbehaun, MD, Miralem Pasic, MD, PhD, Semih.

Published byMadison Booth Modified over 5 years ago

Similar presentations

Presentation on theme: "Transapical aortic valve implantation in patients with severely depressed left ventricular function  Axel Unbehaun, MD, Miralem Pasic, MD, PhD, Semih."— Presentation transcript:

1 Transapical aortic valve implantation in patients with severely depressed left ventricular function 
Axel Unbehaun, MD, Miralem Pasic, MD, PhD, Semih Buz, MD, Stephan Dreysse, MD, Marian Kukucka, MD, Roland Hetzer, MD, PhD, Thorsten Drews, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 143, Issue 6, Pages (June 2012) DOI: /j.jtcvs Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Computed tomographic scans of the chest before (left side) and 1 week after transapical aortic valve implantation (right side) in a 75-year-old male patient with advanced biventricular heart failure, porcelain aorta, severe tricuspid valve regurgitation, previous cardiodefibrillator implantation (ICD), and thrombus formation in the giant left atrium. The patient underwent replacement of the aortic valve and aortic root (28-mm homograft) owing to aortic valve stenosis, endocarditis, and annular abscess formation 13 years before. A biological mitral valve replacement (33-mm Hancock) was performed 2 years previously. Transapical aortic “valve-in-valve” implantation was performed under cardiopulmonary bypass (CPB) of short duration (13 minutes) after femorofemoral cannulation. Left ventricular ejection fraction (LVEF) increased from 20% preoperatively to 40% postoperatively. Functional New York Heart Association class improved from stage IV preoperatively to stage II 8 months after transapical aortic valve implantation. PE, Pleural effusion; RV, right ventricle; RA, right atrium with ICD lead; Ao, aorta with circumferential calcification of the implanted homograft; LV, enlarged left ventricle; LA, giant left atrium with adherent thrombus (Th); MV, 33-mm Hancock prosthesis; AV, 26-mm SAPIEN prosthesis. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 A,Valve deployment according to the “Berlin-addition technique”20 under short duration of cardiopulmonary bypass (black arrow, venous cannula). B, Angiographic results after transapical aortic valve implantation. The patient was preoperatively in cardiogenic shock, in acute renal failure with severe metabolic acidosis, and dependent on epinephrine and intra-aortic balloon counterpulsation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Left ventricular ejection fraction (LVEF) and end-diastolic diameter (LVEDD) in 21 patients with poor left ventricular performance (LVEF ≤ 25%) before and after transapical aortic valve implantation (TAVI). LVEF improved significantly up to 2 weeks after TAVI from 20.4% ± 5.3% to 38.4% ± 11.5%. LVEDD remained unchanged: 57.3 ± 8.6 mm preoperatively and 55.6 ± 8.6 mm postoperatively. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 The Kaplan-Meier survival function for 21 patients with a left ventricular ejection fraction (LVEF) between 10% and 25 % (solid line) and for 237 patients with an LVEF above 25% (dotted line). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Transapical aortic valve implantation in patients with severely depressed left ventricular function  Axel Unbehaun, MD, Miralem Pasic, MD, PhD, Semih."

Similar presentations

Bloodless Surgery of Acute Type A Aortic Dissection in a Jehovah’s Witness Patient  Miralem Pasic, MD, PhD, Wolfgang Ruisz, MD, Andreas Koster, MD, PhD,

Bloodless Surgery of Acute Type A Aortic Dissection in a Jehovah’s Witness Patient  Miralem Pasic, MD, PhD, Wolfgang Ruisz, MD, Andreas Koster, MD, PhD,
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Circ Cardiovasc Interv

Circ Cardiovasc Interv
Lindsay S. Rogers, MD, Amy L. Peterson, MD, J

Lindsay S. Rogers, MD, Amy L. Peterson, MD, J
Edo Bedzra, MD, MBA, Creighton W. Don, MD, Mark Reisman, MD, Gabriel S

Edo Bedzra, MD, MBA, Creighton W. Don, MD, Mark Reisman, MD, Gabriel S
Analysis of Survival in 300 High-Risk Patients up to 2

Analysis of Survival in 300 High-Risk Patients up to 2
First successful transapical aortic valve implantation after aortic allograft replacement  Michael Schmoeckel, MD, Peter Boekstegers, MD, Konstantin Nikolaou,

First successful transapical aortic valve implantation after aortic allograft replacement  Michael Schmoeckel, MD, Peter Boekstegers, MD, Konstantin Nikolaou,
An unusual case of severe aortic valve stenosis in an adult caused by aortic valve inflammatory myofibroblastic tumor  Dong Zhao, MD, Chunsheng Wang,

An unusual case of severe aortic valve stenosis in an adult caused by aortic valve inflammatory myofibroblastic tumor  Dong Zhao, MD, Chunsheng Wang,
Challenging homografts as the holy grail for aortic valve endocarditis

Challenging homografts as the holy grail for aortic valve endocarditis
Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD 

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD 
Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function  Eduard Quintana, MD, Rakesh M. Suri,

Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function  Eduard Quintana, MD, Rakesh M. Suri,
Novel mechanism of mitral regurgitation after lung transplantation in a patient with scleroderma and pulmonary hypertension  Christian A. Bermudez, MD,

Novel mechanism of mitral regurgitation after lung transplantation in a patient with scleroderma and pulmonary hypertension  Christian A. Bermudez, MD,
Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: Effect of nitric oxide inhalation 

Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: Effect of nitric oxide inhalation 
Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,
Patient–prosthesis mismatch after transapical aortic valve implantation: Incidence and impact on survival  Marian Kukucka, MD, Miralem Pasic, MD, PhD,

Patient–prosthesis mismatch after transapical aortic valve implantation: Incidence and impact on survival  Marian Kukucka, MD, Miralem Pasic, MD, PhD,
Introducing transapical aortic valve implantation (part 1): Effect of a structured training program on clinical outcome in a series of 500 procedures 

Introducing transapical aortic valve implantation (part 1): Effect of a structured training program on clinical outcome in a series of 500 procedures 
Femoral vein homograft for neoaortic reconstruction in the Norwood stage 1 operation: A follow-up study  Thomas J. Seery, MD, Pranava Sinha, MD, David.

Femoral vein homograft for neoaortic reconstruction in the Norwood stage 1 operation: A follow-up study  Thomas J. Seery, MD, Pranava Sinha, MD, David.
Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis  Timotheos.

Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis  Timotheos.
Aortic root translocation with atrial switch: Another surgical option for congenitally corrected transposition of the great arteries with isolated pulmonary.

Aortic root translocation with atrial switch: Another surgical option for congenitally corrected transposition of the great arteries with isolated pulmonary.
Timing of valve repair for severe degenerative mitral regurgitation and long-term left ventricular function  Takeshi Kitai, MD, Yukikatsu Okada, MD, Yu.

Timing of valve repair for severe degenerative mitral regurgitation and long-term left ventricular function  Takeshi Kitai, MD, Yukikatsu Okada, MD, Yu.

Similar presentations

Ads by Google